Summary:
A Randomized, Double Blind, Placebo-Controlled Phase 3 study to evaluate the safety and effectiveness of study medication in patients with moderate to severe COPD.
Qualified Participants Must:
• Be 18 years of age or older
•
Have a diagnosis of COPD
•
Have moderate to severe COPD
•
Currently be taking COPD medications
•
Have had COPD exacerbations within the last 12 months requiring treatment or hospitalization
Qualified Participants May Receive:
Compensation for time and travel if qualified